FAP and neoplasm: The theranostic approach exemplified by [137La]La-FAP-2286 offers potential advantages for both tumour detection and treatment monitoring in FAP-expressing malignancies, though further characterisation of its binding affinity, pharmacokinetics, and therapeutic efficacy remains necessary [126].